NL6911533A - - Google Patents

Info

Publication number
NL6911533A
NL6911533A NL6911533A NL6911533A NL6911533A NL 6911533 A NL6911533 A NL 6911533A NL 6911533 A NL6911533 A NL 6911533A NL 6911533 A NL6911533 A NL 6911533A NL 6911533 A NL6911533 A NL 6911533A
Authority
NL
Netherlands
Application number
NL6911533A
Original Assignee
Nysco Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nysco Lab Inc filed Critical Nysco Lab Inc
Publication of NL6911533A publication Critical patent/NL6911533A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00—Esters of nitric or nitrous acid
    • C07C203/02—Esters of nitric acid
    • C07C203/04—Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL6911533A 1969-08-13 1969-07-28 NL6911533A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE737438 1969-08-13

Publications (1)

Publication Number Publication Date
NL6911533A true NL6911533A (en:Method) 1971-02-01

Family

ID=3855190

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6911533A NL6911533A (en:Method) 1969-08-13 1969-07-28

Country Status (4)

Country Link
US (1) US3481955A (en:Method)
BE (1) BE737438A (en:Method)
DE (1) DE1936064A1 (en:Method)
NL (1) NL6911533A (en:Method)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860712A (en) * 1973-04-16 1975-01-14 Sterling Drug Inc Composition and method for treatment of acne or seborrhea

Also Published As

Publication number Publication date
BE737438A (en:Method) 1970-02-13
DE1936064A1 (de) 1971-01-28
US3481955A (en) 1969-12-02

Similar Documents

Publication Publication Date Title
AU2270770A (en:Method)
AU465413B2 (en:Method)
AU429630B2 (en:Method)
AU427401B2 (en:Method)
AU470661B1 (en:Method)
AU428074B2 (en:Method)
AU438128B2 (en:Method)
AU442357B2 (en:Method)
AU442535B2 (en:Method)
AU428129B2 (en:Method)
AT308690B (en:Method)
AU442322B2 (en:Method)
AU442285B2 (en:Method)
AU5988769A (en:Method)
AU6254169A (en:Method)
CS153110B1 (en:Method)
AU6144869A (en:Method)
AU6261969A (en:Method)
AU4923469A (en:Method)
AR203167Q (en:Method)
AU6132869A (en:Method)
AU5079269A (en:Method)
CS153061B2 (en:Method)
CS150483B1 (en:Method)
BE752646A (en:Method)